TITLE:
Two Grams BID Is an Oral Dosage of Vitamin C to Reduce the Risk of Recurrence of Superficial Bladder Carcinoma
AUTHORS:
Edward Folk, Tracy M. Downs, Alfred Roc Ordman
KEYWORDS:
Cancer, Vitamin C, LUTS, Superficial Bladder Carcinoma
JOURNAL NAME:
Journal of Cancer Therapy,
Vol.6 No.2,
February
9,
2015
ABSTRACT:
Background: Continuous exposure to
millimolar (mM) Vitamin C (AA) in vitro kills cancer cells. For superficial
bladder carcinoma (SBC), standard chemotherapy is instillation of Bacillus
Calmette-Guerin. The recurrence rate with this therapy is 91%. But high dosage
vitamins including AA reduced the recurrence to 41%. Aim: To determine the oral
dosage of AA that causes the highest concentration of AA [AA] in the bladder.
Method: We conducted a clinical trial of 14 people who took various dosages of
AA, and analyzed the [AA] in their urine. Results: AA above 2 g twice a day was
not absorbed. But that intake produced a bladder [AA] above 1 mM in all
participants. Conclusion: Taking 2 g of AA BID will increase [AA] in the
bladder to a level likely to kill cancer cells that cause SBC. Taking that
dosage 2 consecutive days a week is likely to reduce the recurrence rate of SBC
substantially.